Missed opportunities for risk reduction: type 1 diabetes management in older adults in DPV and T1DX-QI registries
Despite a high prevalence of ASCVD and risks of hypoglycemia, guideline-recommended treatments including lipid-lowering therapy for secondary prevention and diabetes technologies were used in approximately half or fewer of older adults with T1D. Additional attention to prescribing and practices to support clinicians and older adults in the use of diabetes technologies is urgently needed.
Authors
- Lauren Golden (ORCID: https://orcid.org/0000-0003-4160-8488)
- S Lanzinger
- Saketh Rompicherla
- Kathryn L. Fantasia (ORCID: https://orcid.org/0000-0002-2949-9568)
- Jennifer Grammes (ORCID: https://orcid.org/0000-0002-5894-6734)
- Osagie A. Ebekozien (ORCID: https://orcid.org/0000-0002-8473-249X)
- Florian Kopp
- Julia K Mader
- Peter M Jehle
- Reinhard W Holl
Institutions
- Boston University (US)
- University of Augsburg (DE)
- Wittenberg University (US)
- Universität Ulm (DE)
- Johannes Gutenberg University Mainz (DE)
- Medical University of Graz (AT)
- Luther University (KR)
- NYU Langone Health (US)
- University Medical Center of the Johannes Gutenberg University Mainz (DE)
- T1D Exchange (US)
- Stanford Medicine (US)
- German Center for Diabetes Research (DE)
- Technische Hochschule Ulm (DE)
- Stanford University (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Journal of the Endocrine Society
- Published
- 2026-01-15
- DOI
- https://doi.org/10.1210/jendso/bvag007
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00